Nvidia Data Center Revenue Nearly Doubles as Strong Earnings Report Prompts Stock Decline Bitcoin Drops to SixWeek Low as Geopolitical Deal Fails to Lift Sentiment Abercrombie Fitch Shares Surge on Strong Earnings Marking 14th Consecutive Quarter of Sales Growth Apollo Global and Blackstone Reportedly Working on 36 Billion Debt Financing for Anthropic Standard Chartered to Reduce Corporate Functions Roles by Over 15 in Efficiency Drive Targeting Higher Returns Morgan Stanley Boosts Aflac Price Target to 125 on Insurance Strength WBS Q1 2026 Earnings EPS Beats Estimates as Stock Edges Lower Belden Inc BDC Q1 2026 Earnings EPS Surges Past Expectations on Operational Strength Diageo Q1 2026 Earnings EPS Misses Estimates Amidst Mixed Market Sentiment Fortrea Holdings Inc FTRE Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction VLYPO Q1 2026 Earnings Preferred Stock Posts Modest EPS Beat Amid Limited Revenue Disclosure Gogo Inc GOGO Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Amid Revenue Disclosure Gap Concorde International Group Ltd CIGL Hovers at 199 as Market Awaits Direction Southwest Gas Holdings SWX Holds Steady Near 90 After Modest Gains Ciena Corporation CIEN Slides 215 as Bearish Pressure Intensifies Near Key Support FuelCell Energy FCEL Edges Higher as Key Resistance Test Looms New Oriental Education EDU Edges Lower Amid Sector Headwinds London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance STRW Q1 2026 Earnings Earnings Beat Estimates Despite Modest Stock Decline Rafael Holdings RFL Shows Modest Uptick as Shares Test Key Resistance Levels TRNO Q1 2026 Earnings Stellar EPS Beat of 991 Overshadowed by Slight Stock Decline CBAN Q1 2026 Earnings Earnings Miss Weighs on Results Despite Modest Share Price Gain ABM Q1 2026 Earnings EPS Misses Estimates Despite Operational Progress iSpecimen Inc ISPC Q3 2024 Earnings Wide EPS Miss Amid Operational Challenges Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development NextPlat Corp NXPL Q1 2026 Earnings Loss Widens as Growth Initiatives Weigh on Bottom Line Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus